Rock Springs Capital Management »

Adaptimmune Therapeutics shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 2.4M 0.97
2024-03-31 $3.8M 2.4M 1.58
2023-09-30 $2.2M 2.8M 0.78
2023-06-30 $2.6M 2.8M 0.93
2023-03-31 $3.0M 2.8M 1.09
2022-12-31 $3.9M 2.7M 1.46
2022-09-30 $2.5M 2.4M 1.07
2022-06-30 $4.0M 2.4M 1.70
2022-03-31 $4.7M 2.3M 2.06
2021-12-31 $8.3M 2.2M 3.75
2021-09-30 $11M 2.2M 5.17
2021-06-30 $6.6M 1.5M 4.26
2021-03-31 $8.2M 1.5M 5.31
2020-12-31 $8.3M 1.5M 5.39
2020-09-30 $16M 2.0M 7.98
2020-06-30 $20M 2.0M 10.01
2020-03-31 $3.3M 1.2M 2.72
2019-12-31 $960k 800k 1.20
2019-09-30 $1.3M 875k 1.51
2019-06-30 $3.5M 875k 4.02
2019-03-31 $3.4M 800k 4.30
2018-12-31 $4.3M 750k 5.75
2018-09-30 $10M 750k 13.56
2018-06-30 $8.9M 750k 11.87
2018-03-31 $9.8M 875k 11.23
2017-12-31 $5.8M 875k 6.68
2017-09-30 $7.2M 875k 8.19
2017-06-30 $3.9M 875k 4.49
2017-03-31 $4.8M 875k 5.51
2016-12-31 $2.7M 675k 4.05
2016-09-30 $4.8M 675k 7.05
2016-06-30 $6.2M 765k 8.15
2016-03-31 $6.2M 765k 8.13
2015-12-31 $9.2M 765k 12.06
2015-09-30 $9.1M 756k 11.97
2015-06-30 $17M 905k 18.33